Dermabase

Quick links to important sections

Dermabase

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dermabase

Quick Facts

Property Description
Active Ingredient Emollients Topical (e.g., Petrolatum, Mineral Oil)
Form Cream, Lotion (Oil-in-Water Emulsion)
Pharmacological Class Pharmaceutical Aid, Dermatological
Primary Use Compounding Vehicle, Moisturizer for Dry Skin
Origin Synthetic and Derived

1. Defining Dermabase: A Specialized Pharmaceutical Aid and Vehicle

Dermabase is a specialized topical preparation that functions primarily as a highly stable Pharmaceutical Aid and a Topical Emollient, designed to serve as a neutral vehicle for topical preparations. It is not classified as a drug with its own principal active ingredient, but rather a foundational formulation applied via the topical route of administration. Within the category of Topical Emollients, the formulation is used to soothe and soften the skin, supporting recovery from various forms of dry skin by restoring and maintaining skin moisture. This positioning allows Dermabase to meet the rigorous standards necessary for pharmaceutical compounding.

2. Composition and Form: What Makes This Emulsion Water-Washable?

Dermabase is a combination product that presents as a white, homogenous Cream or Lotion, built upon a sophisticated Oil-in-Water Emulsion Base. The functional components, categorized as Emollients Topical, frequently include purified Mineral Oil, Petrolatum, and fatty alcohols like Cetyl Alcohol, derived from synthetic and purified sources. This specific emulsified structure is a key differentiating feature, ensuring the preparation is notably non-greasy and easily water-washable. The water-washable attribute makes Dermabase a preferred choice for patients requiring frequent or large-area application, addressing the common adherence challenge posed by heavy, residual bases.

3. The Functional Role of Dermabase in Compounding

The core function of this preparation is its strategic utility as a reliable compounding base for custom medication formulation. Its composition creates a mild, protective physical barrier, or occlusive layer, over the skin, which efficiently reduces moisture loss. Crucially, as a vehicle, its stable and chemically inert nature allows pharmacists to achieve uniform dispersal and consistent delivery of various drug molecules. This capability makes Dermabase a pivotal ingredient in creating specialized, patient-specific therapies where a neutral, high-quality, and comfortable base is essential for the effective topical delivery of medication.

Regulatory References

  1. NIH Fact Sheet
  2. DermNet Emollients
  3. NIH Compounding Study

What side effects are possible with Dermabase?

Possible side effects and safety information

The regulatory safety profile for this topical emollient base is primarily defined by high-level constraints and adverse reactions classified under Skin and Subcutaneous Tissue Disorders. As a pharmaceutical aid intended for external use, systemic effects are rare, and the majority of reported issues are localized.

Documented Adverse Reactions

Adverse reactions associated with the use of emollients in this class often involve the application site. Officially documented local effects include skin irritation, redness, folliculitis (inflammation of hair follicles), and the exacerbation of acne (acne-like eruptions). For most localized effects, the occurrence rate is often designated as Frequency Not Known in regulatory documents, meaning the exact prevalence cannot be estimated from available reporting data.

Serious Adverse Reactions and Safety Constraints

Although rare, severe hypersensitivity reactions are possible, which may involve a systemic immune response to an excipient in the formulation. These reactions can manifest as symptoms such as anaphylaxis or angioedema (swelling of the face, tongue, or throat).

Due to the low systemic absorption, regulatory labels typically list no specific safety warnings or dosage adjustments for special populations such as older adults, pediatric use, or individuals with renal or hepatic impairment.

Critical External Safety Note

A critical, mandatory safety constraint noted by government health authorities concerns the Risk of Burns. Clothing, bedding, or dressings that have been saturated with emollient preparations pose a risk of severe and fatal burns if they are exposed to a flame or other sources of ignition, even after washing. This preparation is intended for external use only, and direct contact with the eyes should be avoided.

Overdose and Emergency Response

Dermabase Overdose and When to Seek Help

This information is based strictly on the Overdose section of authoritative government regulatory documents.

Documented Overdose Manifestations

Overdose with Dermabase is officially documented to present with signs of dose-dependent central nervous system (CNS) depression, including somnolence and confusion. Gastrointestinal disturbances, such as nausea and vomiting, are also listed. More severe presentations involve the cardiovascular system, manifesting as hypotension and mild bradycardia.

Official Regulatory Actions

Classification Manifestation/Required Action
Life-Threatening Risks Respiratory depression or arrest; severe cardiovascular events (e.g., profound hypotension, significant arrhythmias).
When to Seek Help Immediate medical attention is required for any sign of respiratory difficulty (e.g., shallow breathing) or prolonged loss of consciousness.
Mandated User Action Immediately contact Emergency Services (e.g., 911/112) or a Poison Control Center if overdose is suspected.

Management and Monitoring

Management of Dermabase overdose is primarily supportive and symptomatic. No specific pharmaceutical antidote is officially recommended by regulatory bodies. Treatment focuses on maintaining a patent airway, providing assisted ventilation if needed, and managing cardiovascular stability with intravenous fluids or vasopressors.

Continuous cardiorespiratory monitoring and frequent neurological status checks are required until the patient is clinically stable, as detailed in the official prescribing information.

Therapeutic Uses of Dermabase

What Dermabase Treats: Main Uses and Benefits

Managing Dryness, Scaling, and Chronic Skin Conditions

Dermabase is commonly used to help provide symptomatic relief for conditions marked by impaired skin barrier function and significant moisture loss. This includes chronic presentations like Eczema and Psoriasis, as well as severe dry skin (Xerosis). Preparations of this type are utilized to manage clusters of symptoms such as skin roughness, scaling, flaking, and associated itching, contributing to the key benefit of sustained hydration to help ease the overall symptom load and support long-term barrier maintenance.

“The preparation is relevant for offering supportive therapeutic benefit in specific contexts of skin stress, such as managing minor irritations or helping to soothe discomfort that can arise from treatments like radiation therapy.”

Its therapeutic domains include relieving dryness, reducing associated itching, supporting barrier maintenance, and facilitating custom medication delivery.


Quick Fact: Relief for Dryness and Itching Domain Primary Benefit
Emolliency Soothing and softening rough skin
Supportive Care Helps manage discomfort from minor irritations
Compounding Assists in creating patient-specific therapies

Eligibility and Restrictions for Use

Eligibility Scope: Official Regulatory Information

The eligibility profile for Dermabase, based on regulatory documentation for non-systemic topical emollients, defines specific population categories for use, contraindication, and caution.

Category Regulatory Status
Populations Allowed Adults, Older Adults, Children, and Infants are generally eligible for use under standard labeled conditions for topical application.
Contraindicated Populations Individuals with a known allergy or hypersensitivity to Dermabase or any of its specific ingredients, including inactive components, are strictly prohibited from use.

Condition-Based Restrictions

Official regulatory guidelines impose restrictions related to the condition of the application site, not systemic health:

  • Compromised Skin: The product must not be applied to infected, broken, bleeding, or ulcerated skin. This is a mandatory restriction based on the integrity of the application area.
  • Sensitive Areas: Use should be avoided near the eyes or mucous membranes unless specifically directed.
  • Systemic Conditions: No restrictions are documented concerning systemic health, such as hepatic or renal impairment, due to the product's negligible systemic absorption.

Use in Pregnancy and Lactation

  • Pregnancy: Use is generally considered safe, but consultation with a healthcare professional is noted in the labeling.
  • Lactation: Use during breastfeeding is a point of caution, as it is unknown if the product passes into breast milk.

What should I know about interactions with other medicines?

The interaction profile for Dermabase is strictly defined by its function as a topical emollient and is documented in official government regulatory sources. Due to its inert composition and negligible systemic absorption, regulatory information confirms the absence of documented systemic interactions, including those involving CYP enzymes, drug transporters, food, alcohol, or supplements.

The primary and clinically significant interaction domain documented is the Occlusion-Mediated Pharmacodynamic Interaction. As an occlusive barrier, the product is officially stated to increase the systemic exposure of other co-administered topical drugs, such as certain Topical Corticosteroids. This is classified as a significant interaction requiring cautious management of the co-administered drug’s absorption.

These interactions establish mandatory constraints on co-administration. A formal timing separation rule is required with specific prescription topical agents, necessitating application at least 2 hours before or 2 hours after the medicated product. Furthermore, regulatory documentation explicitly defines the use of occlusive emollients as a prohibited combination on areas treated with highly sensitive agents, such as Topical Mechlorethamine gels, due to the critical risk of augmented systemic absorption.

Mechanism of Action

How Dermabase Works: Mechanism of Action

Dermabase exerts its function via three primary mechanical and physical mechanisms localized to the stratum corneum and the intercellular lipid lamellae. Firstly, occlusive agents establish a continuous, low-permeability physical layer on the skin surface. This layer targets the pathway of Transepidermal Water Loss (TEWL) by mechanically restricting the evaporation of water vapor from the epidermis. Secondly, humectant components facilitate the passive attraction and retention of water molecules within the superficial skin layers. Thirdly, emollient components are deposited into the intercellular matrix, physically filling microscopic gaps between corneocytes. This combined action structurally reinforces the skin surface integrity and enhances the water content of the stratum corneum. The resulting physiological consequence is the reduction of TEWL, leading to an increase in the flexibility and physical continuity of the outermost skin layer.

Dosage and Administration Information

Dermabase is a topical preparation classified for administration via the dermal route as a cream or lotion. As an emollient formulation, the standard application principle is to apply an adequate amount—often described as a thin film—directly to the affected skin areas. Due to its function in maintaining the skin barrier, the dosing schedule is typically "as needed" or multiple times daily, rather than a fixed regimen. This high-frequency usage pattern is intended for continuous skin hydration, often requiring reapplication after washing.

Usage Contexts and Procedural Structure

The preparation's use falls into two primary contexts: direct application for skin support and service as a pharmaceutical compounding vehicle. In the latter use, the quantity of Dermabase utilized is determined by the total volume required to uniformly disperse a prescribed active drug, following specific compounding standards. For individual use, the preparation is applied while the skin is still damp after washing or bathing to enhance its moisture-retaining function.

For specific populations, the product and its components are used for pediatric applications, including general dry skin and diaper area protection, following the same topical principle. The preparation is strictly for external use only, defining a core procedural condition. The overall use pattern is defined for long-term maintenance and regular support rather than a fixed, short-term treatment course, reflecting its role as a fundamental pharmaceutical aid.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dermabase


Evidence for Use in Managing Dry Skin (Xerosis)

Research has explored emollients, which contain components like the Petrolatum and Mineral Oil found in Dermabase, primarily in short-term clinical trials. These studies focused on outcomes related to physical discomfort involving objective changes in Transepidermal Water Loss (TEWL), which is used to measure changes in the skin barrier, and changes in scores for Skin Hydration.

Studies monitored changes during the study period, where outcomes included reported fluctuations in skin hydration measurements and changes in TEWL scores following topical application. Clinical assessments described patterns of change in objective measures of scores for dryness and associated scores for roughness. The regulatory context notes the patterns observed across multiple studies regarding the basic barrier-supporting properties of this product class.

Evidence for Supportive Care in Chronic Skin Conditions

Systematic reviews and clinical guidelines described the frequent use of this class of products as adjunctive or supportive therapy alongside prescription treatments for conditions like Eczema and Psoriasis. Studies monitored patients to describe how symptoms evolved, and the addition of basic emollient therapy was observed in some studies to align with patterns of symptom stability, particularly concerning dryness.

Long-term effects are not fully established when considering the emollient alone. It is difficult to isolate the exact contribution of the emollient base when it is used simultaneously with potent prescription drug therapies, which introduces a key research limitation.

Evidence for Use as a Compounding Vehicle

Pharmaceutical Science research, including stability studies, confirms Dermabase's structural integrity. Analytical studies reported that the Oil-in-Water emulsion base maintained high physical and chemical stability when subjected to standard pharmaceutical testing protocols. The research describes consistent drug delivery characteristics for the base, enabling uniform dispersal and delivery patterns for common active ingredients added during compounding.

Frequently Asked Questions (FAQ)

Common questions about Dermabase (FAQ)

Q: Is Dermabase considered a steroid medicine?

Official classification documents describe Dermabase as a Topical Emollient and Pharmaceutical Aid formulation. It is not classified as a steroid medicine.

Q: Is Dermabase safe to use on sensitive skin areas?

Regulatory guidelines indicate that the product is intended for application on intact skin only. It should not be applied to skin that is infected, broken, bleeding, or ulcerated. Regulatory documents advise avoiding use near the eyes or mucous membranes unless specifically directed.

Q: Is Dermabase okay for children to use?

Official regulatory documents indicate that Dermabase is designated for use in adults, older adults, children, and infants. It is generally eligible for use across these populations under standard labeled conditions for topical application.

Q: What are the most common side effects people talk about with Dermabase?

Documented local effects often involve the application site. According to official product information, these may include skin irritation, redness, folliculitis (inflammation of hair follicles), and the exacerbation of acne (acne-like eruptions).

Q: What is the risk of a serious side effect from Dermabase?

Due to the product's negligible systemic absorption, systemic effects are uncommon. Official safety documents indicate that severe hypersensitivity reactions are possible. These rare reactions may manifest as symptoms such as swelling (angioedema) or anaphylaxis.

Q: Can Dermabase be used with other topical prescription medicines?

Official regulatory documents confirm that Dermabase can increase the systemic exposure of other co-administered topical drugs, such as certain topical corticosteroids, due to its occlusive properties. A formal timing separation rule is required, which generally advises application at least 2 hours before or 2 hours after the medicated product.

Q: Does the time of day matter when I use Dermabase?

The official labeled use pattern for Dermabase is typically described as “as needed” or “multiple times daily.” This flexible application pattern reflects its role in providing continuous skin hydration and barrier support rather than requiring a fixed time of day.

Q: Why is Dermabase sometimes called by a different name?

Dermabase is a formulation that functions as a pharmaceutical aid and a specific type of emollient base. It is often referred to by its pharmacological class, Topical Emollients, particularly when used as a neutral compounding vehicle for custom medications.

Q: Does Dermabase get absorbed into the rest of the body?

Because of its composition and physical mechanisms of action, regulatory documents confirm the systemic absorption is negligible. This means that very little, if any, of the product enters the rest of the body beyond the application site.

Q: How long does it usually take to see results from Dermabase?

Clinical studies of this product class typically monitor outcomes over short-term clinical trials, focusing on objective changes in skin hydration and the skin barrier function. Official documents do not define a specific expected timeframe for patients to observe initial changes.

Q: What is the main difference between Dermabase and over-the-counter creams?

Dermabase is officially defined as a specialized Pharmaceutical Aid. It is designed to meet the rigorous standards necessary for use as a reliable pharmaceutical compounding base, allowing for the stable and uniform delivery of various drug molecules in patient-specific therapies.

Q: Will I have withdrawal symptoms if I stop using Dermabase suddenly?

Withdrawal symptoms are typically associated with discontinued use of potent medicines like topical corticosteroids. Because this product is a topical emollient and is not classified as a steroid, the official safety profile does not include warnings or information regarding withdrawal symptoms.

Q: Can Dermabase cause the skin to get thinner over time?

The risk of skin thinning (atrophy) is primarily associated with the prolonged use of topical corticosteroids. As Dermabase is classified as a Topical Emollient, its official safety profile does not include warnings about skin thinning.

Q: Are there any foods or drinks that interact with Dermabase?

Due to the product's negligible systemic absorption, regulatory information confirms the absence of documented systemic interactions between Dermabase and common factors like food or alcohol.

Q: Can Dermabase affect other medicines I take for conditions other than skin issues?

Regulatory information confirms the absence of documented systemic interactions between Dermabase and other orally or systemically taken medicines. This is because its systemic absorption is negligible.

Q: Why does my skin feel warm after applying Dermabase?

Official regulatory documents list local effects that may occur at the application site, including skin irritation and redness. A feeling of warmth may align with signs of irritation or a hypersensitivity reaction.

Q: How long after starting Dermabase should I contact my healthcare provider if I don't see any change?

Regulatory safety guidance describes situations where use should be discontinued, such as experiencing symptoms like redness, swelling, itchiness, or irritation. Official labeling does not define a specific time frame for lack of effect, but notes that medical help should be sought if a condition persists or worsens.

Q: Does alcohol use affect how Dermabase works?

Regulatory documents confirm the absence of documented systemic interactions between Dermabase and alcohol. This is primarily due to the product's negligible systemic absorption.

Q: Is Dermabase considered a medicine that cures the condition?

Official documentation describes the overall use pattern for Dermabase as long-term maintenance and regular support. It is classified as a Topical Emollient and a Pharmaceutical Aid and is not classified as a curative medicine.

Q: Can Dermabase be used for non-skin conditions?

The product is officially classified as a dermal route preparation and a dermatological pharmaceutical aid. Its function is based on physical mechanisms localized to the skin's outer layer, supporting its use for skin-related concerns.

Q: Can Dermabase interact with herbal supplements?

Regulatory documents confirm the absence of documented systemic interactions between Dermabase and herbal supplements. This conclusion is based on the product's negligible systemic absorption.

Q: Is it possible to become resistant to the effects of Dermabase?

Because Dermabase functions primarily via physical and mechanical mechanisms (occlusion and humectancy) localized to the skin barrier, the official regulatory profile does not include warnings or information concerning the development of pharmacological resistance or tolerance.

Q: What should I do if Dermabase gets into my eyes?

Official safety guidance indicates that direct contact with the eyes should be avoided. If contact accidentally occurs, the affected area should be immediately rinsed well with water as described in safety documents.

Q: Is Dermabase used for psoriasis or just eczema?

Systematic reviews and clinical guidelines describe the frequent use of this product class as adjunctive or supportive therapy alongside prescription treatments for both Eczema and Psoriasis. It is used to help manage symptoms associated with dry skin in both conditions.

Q: If I have a kidney problem, can I still use Dermabase?

Due to the product's negligible systemic absorption, regulatory labels typically list no specific safety warnings or dosage adjustments for individuals with systemic conditions like renal or hepatic impairment.

Q: Do studies exist that compare Dermabase to a placebo?

Research has explored emollients, which contain the components of Dermabase, primarily in short-term clinical trials. These studies often focus on objective physical outcomes such as changes in Transepidermal Water Loss (TEWL) and Skin Hydration.

Q: If I forget the information, where can I find official documents about Dermabase?

Authoritative medical information about Dermabase, including its safety and use, can be found in government-issued sources. These include resources like the NIH DailyMed and MedlinePlus, or through other national regulatory bodies.

Q: Are there common household products I should avoid while using Dermabase?

A critical safety note from government health authorities concerns the Risk of Burns. Clothing, bedding, or dressings saturated with the product pose a risk of severe burns if exposed to a flame or other sources of ignition. Regulatory documents highlight the importance of avoiding ignition sources when the product is in contact with fabrics.

Q: Is Dermabase the same as the generic version?

Official documentation describes Dermabase as a specialized Topical Emollient and Pharmaceutical Aid used as a compounding vehicle. It is generally referred to by its pharmacological class, and some sources indicate there is no direct generic equivalent for the specific compounded base.

Q: How is the safety of Dermabase tracked after it is approved?

The safety of pharmaceutical products is continuously monitored by government health authorities through mandatory reporting of adverse reactions. This ongoing process is why the occurrence rate of many reported side effects is officially designated as Frequency Not Known from available data.

Q: Is there a link between Dermabase and sun sensitivity?

Some ingredients in this product class may increase sensitivity to the sun. Regulatory safety information typically includes instructions related to limiting time in the sun, avoiding tanning beds, and wearing protective clothing while using the product.

Q: Does Dermabase contain any ingredients that cause allergic reactions?

Official regulatory guidelines strictly prohibit use in individuals with a known allergy or hypersensitivity to Dermabase or any of its specific ingredients, including inactive components (excipients).

Q: What are the official warnings about using Dermabase?

The critical warning concerns the Risk of Burns from saturated clothing or bedding exposed to a flame. Official documents indicate that use should generally be avoided near the eyes or mucous membranes unless specifically directed by a healthcare professional.

Q: What happens if you miss an application of Dermabase?

Because the product is typically applied “as needed” for continuous skin hydration and barrier maintenance, official guidance for emollients describes the application of the missed amount as soon as it is remembered, then continuing with the regular schedule.

Q: Is Dermabase a medicine that needs to be used long-term?

The overall use pattern for Dermabase is officially defined for long-term maintenance and regular support. This reflects its fundamental role as a pharmaceutical aid intended for continuous skin hydration and barrier integrity.

Q: Is Dermabase a treatment for acne?

Dermabase is not labeled as a treatment for acne. Its primary uses are as a compounding vehicle and moisturizer for dry skin. Official regulatory documents list the exacerbation of acne as a documented local effect, which is a key safety consideration.

How should Dermabase be stored and disposed of?

Dermabase cream must be stored to keep out of reach of children and away from extreme temperatures. Regulatory documents specify that the cream must not be stored in areas of extreme heat or cold and must be protected from direct sunlight. The container should be kept tightly closed when not in use to maintain the integrity of the emulsion.

Disposal Instructions

The disposal of any unused or expired product should follow official guidelines. The preferred method is to use a drug take-back program or mail-back envelope. If a take-back option is unavailable, the medicine must be removed from the container, mixed with an undesirable substance (like coffee grounds), sealed in a leak-proof bag, and placed in the household trash. It is strictly advised not to flush the cream down the toilet unless specific instructions on the labeling direct otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dermabase found in:

A-Z Index: